Trial Profile

Impact of two thrombelastography-guided strategies of fibrinogen correction on blood product requirements in liver transplantation: a multicenter, randomized trial.TROMBOFIB trial

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Jan 2023 Primary endpoint (Evaluation of the rate of red blood cell packs transfusion during procedure and in the first 24hours after between groups) has not been met according to Results published in the Journal of Thrombosis and Haemostasis.
01 Jan 2023 Results hypothesized that infusions of fibrinogen concentrate to reach an A10(FibTem) value of 11 mm during LT could reduce red blood cell (RBC) and other component and fluid requirements in comparison to standard care published in the Journal of Thrombosis and Haemostasis
08 May 2022 This trial has been completed in Spain, according to European Clinical Trials Database record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com